Sabra Health Care REIT, Inc. | REIT Profile
Symbol: SBRA
CIK: 1492298
Exchange: NASDAQ
Founded: 2010 (15 years)
HQ: Irvine, CA, United States
Type of REIT: Equity REIT
Listing Status: Public
Market Capitalization: Mid-Cap
REIT Sector: Health Care
See SBRA on Yahoo Finance
See SBRA on SEC.gov
 |
 |
 |
As a leading healthcare REIT, we own and invest in real estate serving the healthcare industry throughout the United States and Canada, including skilled nursing, senior housing and behavioral health facilities. Our passion for quality care and vast industry experience uniquely position Sabra to succeed in the dynamic healthcare real estate market.
Stock Chart
REITMovers
REITMovers tracks the stock price and other indicators for all US REITs tracked by REITNotes during normal trading hours. This data is updated every 4 minutes during normal trading hours. Note: All prices have a 15 minute delay.
| Latest Price | High | Low | Open | Previous Close | Volume | Change $ | Change % |
|---|---|---|---|---|---|---|---|
| $18.07 | $18.38 | $17.79 | $17.90 | $17.89 | 3,039,155 | $0.18 | 1.01% |
Last update: 2025-05-08 13:00:51 PST
REITRating™ Trend
REITRating™ is REITNotes' Real Estate Investment Trust industry-specific rating and ranking system. The overall score is out of ten points, with ten being the best score. See score breakdown. The graph below plots the overall REITRating™ score for the last trading days. See complete trend.
Dividend of Trading Day 2025-05-08
Annualized Dividend: $1.2*
Dividend Yield (TTM): 6.7%
Annualized Dividend (TTM): $1.2
Ex-Dividend Date: 2025-02-14
Dividend Date: 2025-02-28
Dividend Frequency: Quarterly
*The forward annualized dividend and dividend yield are based on the most recent dividend value paid by the REIT. The REIT may have already announced their next upcoming dividend value, which may be different from previously paid dividend value. It is recommended to check the REIT's website and dividend announcements for the latest information on upcoming dividends and changes. This graph does not include extraordinary dividend.
Latest REIT Press Releases
- Sabra Healthcare REIT - Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance - Mon, 05 May 2025 20:05:31 UTC
- Sabra Healthcare REIT - Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition - Mon, 24 Mar 2025 13:20:26 UTC
- Sabra Healthcare REIT - Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance - Wed, 19 Feb 2025 21:05:29 UTC
- Sabra Healthcare REIT - Sabra Health Care REIT, Inc. Announces Leadership Promotions - Mon, 17 Feb 2025 21:05:44 UTC
- Sabra Healthcare REIT - Sabra Health Care REIT, Inc. Announces Tax Treatment of 2024 Distributions - Fri, 24 Jan 2025 21:05:42 UTC
Funds From Operations (FFO)
FFO Amount and Payout Ratio
Below are the FFO amounts, dividends, and payout ratios for the last two quarters for SBRA.
| Year | Quarter | Type | Amount | Dividend Paid | Payout Ratio |
|---|---|---|---|---|---|
| 2024 | Q4 | Normalized AFFO | $--- | $--- | ---% |
| 2024 | Q4 | Normalized FFO | $--- | $--- | ---% |
| 2024 | Q3 | Normalized AFFO | $--- | $--- | ---% |
| 2024 | Q3 | Normalized FFO | $--- | $--- | ---% |
REITNotes uses the REIT's Funds From Operation (FFO) per diluted share informed in the REIT’s Quarterly Earning Reports and its announced dividend per diluted share. For some REITs, we also display the Adjusted Funds From Operations (AFFO), Core FFO, Normalized FFO (NFFO), Modified FFO (MFFO), Operating FFO as provided by the REIT. REITNotes™ calculates the payout ratio by dividing the dividend value paid during the current quarter by the FFO declared in the previous Quarter. E.g., we divide the dividend value paid in Q3 by the FFO reported in Q2. This is because although paid in Q3, the dividend value is usually declared during the previous quarter. FFO is a non-GAAP measure recognized by the SEC and provided by the REITs as a supplemental measure of their operating performance. FFO is not meant to be an indicator of the REIT’s capacity to pay current or future dividends nor to be a substitute to the REIT's cash flow from operations. It is recommended to check the REIT's website, Earning Reports and dividend announcements for the latest and updated information.
Key Stats of Trading Day 2025-05-08
EBITDA: $421,187,000 [?]
P/E (Price-to-Earnings) Ratio: 32.00 [?]
PEG (Price/Earnings to Growth) Ratio: 3.15 [?]
Book Value: 11.54 [?]
Dividend Per Share (DPS): $1.20 [?]
Earnings Per Share (EPS): 0.54 [?]
Revenue Per Share (TTM): $3.01 [?]
Profit Margin: 18.00% [?]
Operating Margin (TTM): 37.10% [?]
Return on Equity (TTM): 4.60% [?]
Revenue (TTM): $702,638,000 [?]
Gross Profit (TTM): $476,121,000 [?]
Diluted EPS (TTM): $0.54 [?]
Quarterly Earnings Growth YOY: 182.70% [?]
Quarterly Revenue Growth YOY: 12.50% [?]
Trailing P/E: 32.00 [?]
Forward P/E: 8.71 [?]
Beta: 0.85 [?]
Price-to-Book (P/B): 1.51 [?]
Enterprise Value (EV) to Revenue: 9.28 [?]
EV to EBITDA: 15.82x [?]
Shares Outstanding: 237,936,000 [?]
52 Week High: $19.35 [?]
52 Week Low: $13.15 [?]
50 Day Moving Average: $17.21 [?]
200 Day Moving Average: $17.45 [?]
Properties Owned by SBRA
Sample of REIT’s Properties. Image Source - REIT’s website
Occupancy Rate
REIT Simulation
Below is a simulation of how much money you would have made in dividends, and how much the shares would be worth had you purchased them 1 year ago for the amounts below.
| With $1,000 USD | With $500 USD | With $250 USD | With $100 USD | With $50 USD | |
|---|---|---|---|---|---|
| Initial investment | @ $16.46 per share you would have been able to buy 60 shares of SBRA on 2024-05-08 costing $987.60 | @ $16.46 per share you would have been able to buy 30 shares of SBRA on 2024-05-08 costing $493.80 | @ $16.46 per share you would have been able to buy 15 shares of SBRA on 2024-05-08 costing $246.90 | @ $16.46 per share you would have been able to buy 6 shares of SBRA on 2024-05-08 costing $98.76 | @ $16.46 per share you would have been able to buy 3 shares of SBRA on 2024-05-08 costing $49.38 |
| Current worth | On 2025-05-08 these 60 shares would be worth $1,084.20 @ $18.07 | On 2025-05-08 these 30 shares would be worth $542.10 @ $18.07 | On 2025-05-08 these 15 shares would be worth $271.05 @ $18.07 | On 2025-05-08 these 6 shares would be worth $108.42 @ $18.07 | On 2025-05-08 these 3 shares would be worth $54.21 @ $18.07 |
| Dividends earned | $90.00 in dividends would have been earned since 2024-05-08 with 60 shares. | $45 in dividends would have been earned since 2024-05-08 with 30 shares. | $22.50 in dividends would have been earned since 2024-05-08 with 15 shares. | $9.00 in dividends would have been earned since 2024-05-08 with 6 shares. | $4.50 in dividends would have been earned since 2024-05-08 with 30 shares. |
| Net (gain / loss)* | 186.60 USD | 93.30 USD | 46.65 USD | 18.66 USD | 9.33 USD |
| ROI** | 18.89% | 18.89% | 18.89% | 18.89% | 18.89% |
*Net (Gains/Loss): Includes the stock price (appreciate or depreciate ) + dividends earned during period held. Stock prices based on closing price for the date. **ROI: Is based on the Net (gain/loss) divided by the initial investment value. Note: Past performance is no guarantee of future results. This is a high-level simulation and does not account for many factors such as inflation and taxes so we cannot guarantee the accuracy of this simulation.
Dividend History
Below are the most recent cash dividends paid by SBRA. The percent difference from one dividend payment to the next has also been calculated for your convenience. Dividends flagged as [E] are extraordinary dividend payments.
| Symbol | Ex Date | Cash Amount | Change in Dividend | Declaration Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| SBRA | 2025-05-16 | 0.300 | --- | 2025-05-05 | 2025-05-16 | 2025-05-30 |
| SBRA | 2025-02-14 | 0.300 | --- | 2025-02-03 | 2025-02-14 | 2025-02-28 |
| SBRA | 2024-11-15 | 0.300 | --- | 2024-10-31 | 2024-11-15 | 2024-11-29 |
| SBRA | 2024-08-19 | 0.300 | --- | 2024-08-07 | 2024-08-19 | 2024-08-30 |
| SBRA | 2024-05-17 | 0.300 | --- | 2024-05-08 | 2024-05-20 | 2024-05-31 |
| SBRA | 2024-02-12 | 0.300 | --- | 2024-02-01 | 2024-02-13 | 2024-02-29 |
| SBRA | 2023-11-16 | 0.300 | --- | 2023-11-06 | 2023-11-17 | 2023-11-30 |
| SBRA | 2023-08-16 | 0.300 | --- | 2023-08-07 | 2023-08-17 | 2023-08-31 |
| SBRA | 2023-05-15 | 0.300 | --- | 2023-05-03 | 2023-05-16 | 2023-05-31 |
| SBRA | 2023-02-10 | 0.300 | --- | 2023-02-01 | 2023-02-13 | 2023-02-28 |
| SBRA | 2022-11-16 | 0.300 | --- | 2022-11-07 | 2022-11-17 | 2022-11-30 |
| SBRA | 2022-08-16 | 0.300 | --- | 2022-08-03 | 2022-08-17 | 2022-08-31 |
| SBRA | 2022-05-13 | 0.300 | --- | 2022-05-04 | 2022-05-16 | 2022-05-31 |
| SBRA | 2022-02-10 | 0.300 | --- | 2022-02-01 | 2022-02-11 | 2022-02-28 |
| SBRA | 2021-11-15 | 0.300 | --- | 2021-11-03 | 2021-11-16 | 2021-11-30 |
| SBRA | 2021-08-16 | 0.300 | --- | 2021-08-04 | 2021-08-17 | 2021-08-31 |
| SBRA | 2021-05-14 | 0.300 | --- | 2021-05-05 | 2021-05-17 | 2021-05-28 |
| SBRA | 2021-02-11 | 0.300 | --- | 2021-02-02 | 2021-02-12 | 2021-02-26 |
| SBRA | 2020-11-13 | 0.300 | --- | 2020-11-05 | 2020-11-16 | 2020-11-30 |
| SBRA | 2020-08-14 | 0.300 | --- | 2020-08-05 | 2020-08-17 | 2020-08-31 |
Financial Statements Overview
Balance Sheet | Quarterly
| Assets | 2024-12-31 | 2024-09-30 | QoQ |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents at Carrying Value | 60,468,000 | 63,004,000 | |
| Short-Term Investments | 0 | 0 | |
| Cash and Short Term Investments | 60,468,000 | 63,004,000 | |
| Current Net Receivables | 0 | 0 | |
| Inventory | 0 | 68,976,000 | |
| Other Current Assets | 5,871,000 | 5,972,000 | |
| Total Current Assets | 579,562,000 | 184,460,000 | 214.2% |
| Non-Current Assets | |||
| Property Plant Equipment | 0 | 0 | |
| Accumulated Depreciation Amortization PPE | 0 | 0 | |
| Long-Term Investments | 182,919,000 | 190,619,000 | |
| Investments | 0 | 0 | |
| Intangible Assets Excluding Goodwill | 27,464,000 | 28,790,000 | |
| Goodwill | 0 | 0 | |
| Intangible Assets | 27,464,000 | 28,790,000 | |
| Other Non-Current Assets | 0 | 0 | |
| Total Non-Current Assets | 4,724,117,000 | 28,790,000 | 16,308.9% |
| Total Assets | 5,303,679,000 | 5,366,126,000 | -1.2% |
| Liabilities | |||
| Current Liabilities | |||
| Current Accounts Payable | 0 | 0 | |
| Deferred Revenue | 0 | 0 | |
| Current Debt | 0 | 0 | |
| Short-Term Debt | 1,762,872,000 | 1,764,118,000 | |
| Current Long-Term Debt | 106,554,000 | 0 | |
| Short Long-Term Debt Total | 1,762,872,000 | 2,498,477,000 | |
| Other Current Liabilities | 0 | 1,764,118,000 | |
| Total Current Liabilities | 1,762,872,000 | 1,764,118,000 | -0.1% |
| Non-Current Liabilities | |||
| Long-Term Debt Noncurrent | 0 | 0 | |
| Long-Term Debt | 2,311,094,000 | 2,470,207,000 | |
| Capital Lease Obligations | 26,847,000 | 28,270,000 | |
| Other Non-Current Liabilities | 0 | 0 | |
| Total Non-Current Liabilities | 799,519,000 | 2,498,477,000 | |
| Total Liabilities | 2,562,391,000 | 2,621,282,000 | -2.2% |
| Shareholders' Equity | |||
| Common Stock | 2,376,000 | 2,366,000 | |
| Common Stock Shares Outstanding | 239,640,053 | 237,043,400 | |
| Treasury Stock | 0 | 0 | |
| Retained Earnings | -1,874,633,000 | -1,849,168,000 | |
| Total Shareholder Equity | 2,741,288,000 | 2,744,844,000 | -0.1% |
Amounts in USD ($)
Income Statement | Quarterly
| 2024-12-31 | 2024-09-30 | QoQ | |
|---|---|---|---|
| Total Revenue | 182,346,000 | 178,001,000 | 2.4% |
| Cost of Revenue | 59,838,000 | 48,489,000 | |
| Cost of Goods and Services Sold | 59,838,000 | 48,489,000 | |
| Gross Profit | 122,508,000 | 129,512,000 | -5.4% |
| Research and Development | 0 | 0 | |
| Selling General and Administrative | 13,032,000 | 12,404,000 | |
| Depreciation | 0 | 0 | |
| Depreciation and Amortization | 42,308,000 | 42,720,000 | |
| Operating Expenses | 55,215,000 | 12,404,000 | |
| Operating Income | 67,293,000 | 64,521,000 | 4.3% |
| EBIT (Earnings Before Interest and Tax) | 75,158,000 | 58,990,000 | |
| Investment Income Net | 0 | 0 | |
| Net Interest Income | -28,083,000 | -29,467,000 | |
| Interest Income | 0 | 0 | |
| Interest Expense | 28,083,000 | 29,467,000 | |
| Interest and Debt Expense | 0 | 0 | |
| Non Interest Income | 0 | 0 | |
| Other Non Operating Income | 0 | 0 | |
| Income Before Tax | 47,075,000 | 29,523,000 | 59.5% |
| Income Tax Expense | 380,000 | -265,000 | |
| Net Income from Continuing Operations | 46,695,000 | 29,788,000 | |
| Net Income | 46,695,000 | 29,788,000 | 56.8% |
| Comprehensive Income Net of Tax | 0 | 0 | |
| EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) | 117,466,000 | 101,710,000 |
Amounts in USD ($)
Cash Flow | Quarterly
| Cash Flows from Operating Activities | 2024-12-31 | 2024-09-30 | QoQ |
|---|---|---|---|
| Net Income | 46,695,000 | 29,788,000 | 56.8% |
| Depreciation, Depletion, and Amortization | 42,308,000 | 42,720,000 | |
| Change in Receivables | 0 | 0 | |
| Change in Inventory | 0 | 0 | |
| Change in Operating Assets | 0 | 0 | |
| Change in Operating Liabilities | 0 | 0 | |
| Payments for Operating Activities | 0 | 0 | |
| Proceeds from Operating Activities | 0 | 0 | |
| Profit Loss | 0 | 0 | |
| Net Cash Provided by Operating Activities | 79,968,000 | 97,650,000 | -18.1% |
| Cash Flows from Investing Activities | |||
| Capital Expenditures | 0 | 0 | |
| Net Cash Used in Investing Activities | 0 | 0 | |
| Cash Flows from Financing Activities | |||
| Proceeds from Issuance of Common Stock | 0 | 0 | |
| Proceeds from Issuance of Preferred Stock | 0 | 0 | |
| Proceeds from Issuance of Long-Term Debt | 0 | 0 | |
| Proceeds from Repurchase of Equity | 0 | 0 | |
| Proceeds from Sale of Treasury Stock | 0 | 0 | |
| Repayment of Short-Term Debt | 0 | 0 | |
| Payments for Repurchase of Common Stock | 0 | 0 | |
| Payments for Repurchase of Preferred Stock | 0 | 0 | |
| Payments for Repurchase of Equity | 0 | 0 | |
| Dividend Payout | 70,976,000 | 70,280,000 | |
| Dividend Payout - Common Stock | 70,976,000 | 70,280,000 | |
| Dividend Payout - Preferred Stock | 0 | 0 | |
| Net Cash Provided by Financing Activities | -100,964,000 | -13,955,000 | 623.5% |
| Other Items | |||
| Effect of Exchange Rate on Cash | 0 | 0 | |
| Net Increase in Cash and Cash Equivalents | 0 | 0 |
Amounts in USD ($)
REITRating™ Scorecard
| Rating | Dividend Section | Avg. Rating |
|---|---|---|
| 3 | Dividend Payment Growth: Analysis of how the REIT’s dividend payments have performed during the last three years. | 5.0 |
| 10 | Dividend Payment Consistency: Analysis of how many periods the REIT’s dividends have been paid consistently without a gap in payment. | 8.0 |
| 10 | Dividend to Normalized AFFO Payout Ratio Health: Analysis of the REIT’s Dividend to Normalized AFFO Payout Ratios during the last four quarters. | 9.0 |
| 10 | Dividend to Normalized AFFO Payout Ratio Trend: Analysis of the REIT’s Dividend to Normalized AFFO Payout Ratios trend during the last two years. | 7.5 |
| Rating | AFFO & Efficiency Section | Avg. Rating |
| 10 | Normalized AFFO Trend: Analysis of the REIT’s Normalized AFFO trend during the last two years. | 8.7 |
| 5 | Normalized AFFO to Revenue Health: Analysis of the REIT's Adjusted Funds From Operation to its Revenues. | 4.6 |
| 10 | Operating Expense Efficiency: Analysis of the REIT's Operating Expenses to its Revenues. | 9.6 |
| 7 | Operating Expense Efficiency Trend: Analysis of the trend of the REIT's Operating Expenses to its Revenue. | 8.8 |
| Rating | Leverage Section | Avg. Rating |
| 7 | Debt Leverage Health: Analysis of the REIT’s Total Debt to Total Assets. | 5.2 |
| 8 | Debt Leverage Health Trend: Analysis of the REIT’s Total Debt to Total Assets over the last two years. | 6.8 |
| Rating | Asset & Revenue Section | Avg. Rating |
| 8 | G&A Effeciency Level: Analysis of the REIT’s General and Administrative expenses in relationship to its Revenues. | 6.4 |
| 9 | G&A Effeciency Trend: Analysis of the Trend of the REIT’s General and Administrative expenses in relationship to its Revenues. | 7.5 |
| 9 | Revenues Growth: Analysis of how the REIT's Revenue has performed over the last two years. | 6.3 |
| 5 | Total Asset Growth: Analysis of how the REIT has grown its Total Assets over the last two years. | 6.0 |
| Rating | Properties Section | Avg. Rating |
| 7 | Occupancy Health Level: Analysis of the REIT’s occupancy health level during the last four quarters. | 7.8 |
| 8 | Occupancy Trend: Analysis of the REIT’s occupancy trend over the last two years. | 7.7 |
| 7 | Tenants: Analysis of the REIT's tenant diversification, operation type, and exposure to risk. | 8.1 |
| Rating | Market Cap Section | Avg. Rating |
| 7 | Market Cap Strength: Analysis of the REIT's Market Capitalization performance, preservation and resistance in comparison to market changes. | 5.2 |
| 7.9 | Overall REITRating™ Score (See trend) | 6.6 |
REITRating is REITNote's Real Estate Investment Trust industry-specific rating and ranking system. The REIT’s score for each analysis is out of ten points, with ten being the best score and zero being the worst. A score of zero can be assigned if the REIT does not meet the criteria for that specific analysis. N/A is assigned if insufficient data is available for a particular analysis. Our REITRating logic is continuously improving, so a REIT’s rating and ranking may change over time. Important Note: REITRating is not a predictor of a REIT’s future performance, it is an evaluation of its past results. Additionally, the REITRating system is for informational purposes only and does not represent financial or investment advice or a recommendation of which REITs to acquire. Learn more.
REITProperty
| Name | Type | Address | City | State |
|---|---|---|---|---|
| 6006 SE Adams Blvd | Skilled Nursing - Transitional Care | 6006 SE Adams Blvd | Bartlesville | OK |
| 246 Berger Street | Senior Housing | 246 Berger Street | Green Bay | WI |
| 3901 East 4th St | Skilled Nursing - Transitional Care | 3901 East 4th St | Long Beach | CA |
Related REITs
| REIT | REITRating™ Score | Exchange | Market Capitalization | Sector | Country |
|---|---|---|---|---|---|
| Ventas, Inc. (VTR) | 8.0 | NYSE | Large-Cap | Health Care | United States |
| Universal Health Realty Income Trust (UHT) | 8.1 | NYSE | Small-Cap | Health Care | United States |
| Summit Hotel Properties, Inc. (INN) | 8.2 | NYSE | Small-Cap | Hotel Resorts | United States |
| Welltower, Inc. (WELL) | 9.1 | NYSE | Large-Cap | Health Care | United States |
Last updated: 2025-05-08 - v6.3